Contineum Therapeutics Inc - Class A

CTNM NASDAQ Santé & Biotech États-Unis
11.30 $
1.14 %

Contineum Therapeutics Inc est une société biopharmaceutique engagée dans la recherche et le développement de thérapies innovantes pour les maladies inflammatoires et auto-immunes.

Price history of Contineum Therapeutics Inc - Class A
Price history of Contineum Therapeutics Inc - Class A

Performance & Momentum

6 Months 6.94 %
1 Year 154.46 %
3 Years 25.97 %
5 Years 25.97 %

Similar stocks to Contineum Therapeutics Inc - Class A

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone